Table 1.
Tail moments of human lymphocytes exposed to different treatments
| Treatment | N | Tail moment Mean±SE |
|---|---|---|
| Negative control | 30 | 29.2+0.9 |
| H2O2 (2.75%) | 30 | 72.1+1.5* |
| Solvent (EtOH) | 3 | 24.2+2.1 |
| PbTx-2 10−8 M (Sigma) | 6 | 41.3+3.6* |
| PbTx-2 10−12 M (Sigma) | 3 | 46.85+1.5* |
| PbTx-2 10−8 M (UNCW) | 3 | 49.4+9.9* |
| PbTx-2 10−12 M (UNCW) | 3 | 41.8+8.1* |
| PbTx-3 10−8 M (UNCW) | 6 | 64.0+6.4* |
| PbTx-3 10−12 M (UNCW) | 3 | 41.4+5.2* |
| PbTx-9 10−8 M (Sigma) | 3 | 57.0+5.3* |
| PbTx-9 10−12 M (Sigma) | 3 | 41.0+2.9* |
Significantly different from the negative control, p<0.05.